Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology—New Possibility to Decrease Cardiovascular Risk?

Table 1

Basic characteristic of the study group.

	Study group	HbA1c before the study		Improved HbA1c after 3-month follow-up
		<7.5%	≥7.5%	Yes	No
Number of patients	40	8	32	27	13
Age (years)	14.6 ± 2.1	15 ± 1	14.5 ± 2	14.4 ± 2	15.1 ± 1
Gender (boys/girls)	19/21	4/6	15/15	15/12	4/9
Diabetes duration (yrs)	7.4 ± 3.6	6.5 ± 2.7	7.6 ± 3.8	7 ± 4	8 ± 2.2
Height (m)	1.6 ± 0.1	1.7 ± 0.1	1.6 ± 0.1	1.6 ± 0.1	1.7 ± 0.0
Body mass (kg)	59 ± 9.9	64 ± 3.8	58 ± 10	58 ± 10	62 ± 8
Body mass index (kg/m^2)	21.6 ± 3.1	21 ± 1.8	21.8 ± 3	22 ± 3	21 ± 2.4
SDS-BMI	0.6 ± 1.0	0.3 ± 0.8	0.7 ± 1	0.8 ± 1	0.2 ± 0.8
Cholesterol (mg/dL)	167.2 ± 29.1	138.3 ± 9.8	174.4 ± 27.9	169.9 ± 34.4	161.5 ± 11.6
LDL (mg/dL)	88.0 ± 25.7	73.5 ± 10.1	91.7 ± 27.2	88.4 ± 28.6	87.3 ± 19.1
HDL (mg/dL)	64.7 ± 16.7	48.0 ± 3.6	68.8 ± 16.0	67.2 ± 16.7	59.4 ± 15.9
TG (mg/dL)	70.7 ± 21.1	80.8 ± 26.9	68.1 ± 19.1	69.8 ± 16.7	72.4 ± 16.7
SBP (mmHg)	116.1 ± 7.1	125.0 ± 6.5	113.8 ± 5.2	116.6 ± 8.0	114.9 ± 4.7
DBP (mmHg)	71.1 ± 4.9	74.0 ± 5.5	70.3 ± 4.6	71.8 ± 4.8	69.5 ± 5.1
HbA1c (%) before study	9.3 ± 1.5	7.2 ± 0.2	9.8 ± 1.2	9.0 ± 1.3	10 ± 1.7

Data are presented as mean ± SD.